18th ICID | International Congress on Infectious Diseases, Buenos Aires, Argentina

Industry Sponsored Symposia (Updated February 23, 2018)

Industry Sponsored Symposia are commercially sponsored sessions held in conjunction with the
18th International Congress on Infectious Diseases/XVIII Congreso SADI. Sessions are open to all registered congress attendees at no charge. Note: Attending this session does not earn Continuing Education (CE) credits.

Friday, March 2, 2018
Success in managing CA-RTIs and reducing antimicrobial resistance – can both be achieved?
Sponsored by GlaxoSmithKline
Friday, March 2, 2018, 10:15 - 12:15hrs, Libertador C
    Welcome and Introduction
    Gustavo Lopardo (Argentina)
    Puja Kochhar (GSK)

  • Rational use of antimicrobials in upper respiratory tract infections in children
    Marco Aurelio Safadi (Brazil)
  • Clinical impact of antimicrobial surveillance in the management of infected patients
    Jorgelina Smayevsky (Argentina)
  • Management of CA-RTIs – importance of guideline adherence
    Gustavo Lopardo (Argentina)

    Panel discussion and Q&A

    Concluding and Summing Up
    Gustavo Lopardo (Argentina)
    Puja Kochhar (GSK)
Expanding Prevention with Meningococcal B Vaccine
Sponsored by GlaxoSmithKline
Friday, March 2, 2018, 12:30 - 13:45hrs, Libertador C
    Welcome and Introduction
    Angelika Banzhoff (Germany)

  • Experience with Meningococcal B Vaccines in outbreaks and national infant vaccination programs
    Angelika Banzhoff (Germany)
  • Meningococcal disease in Argentina: Room to expand prevention
    Angela Gentile (Argentina)
  • Expanding meningococcal protection: strategies based on epidemiology
    Marco Aurelio Safadi (Brazil)

    Panel discussion
    Maria Gabriela Graña (Argentina)

    Concluding Remarks and Q&A
  • Angelika Banzhoff (Germany)
Public Health Impact of Pneumococcal Conjugate Vaccines and Remaining Burden of Pneumococcal Disease
Sponsored by Pfizer
Friday, March 2, 2018, 15:15 - 16:45hrs, Libertador A
    Welcome and Introduction
    Carla Vizzotti (Argentina)

  • The Impact of Pneumococcal Conjugate Vaccines on Public Health
    Ron Dagan (Israel)
  • Reevaluating the Remaining Burden of Pneumococcal Disease in Adult
    Julio Ramirez (USA)

    Faculty Question and Answer Session
  • Carla Vizzotti (Argentina)
Adult Vaccine: Prevention of Pneumococcal Disease in the Older Adult Population
Sponsored by MSD
Friday, March 2, 2018, 17:00 - 18:00hrs, Libertador B
    Welcome and Introduction
    Pablo Bonvehi (Argentina)

  • Importance of Pneumococcal Surveillance Systems in Latin America
    Maria Cristina de Cunto Bandileone (Brazil)
  • Rationale of Pneumococcal Vaccination in the Older Adult Population
    David Weber (USA)

    Panel Q&A
    Pablo Bonvehi (Argentina)
Saturday, March 3, 2018

Challenges and Solutions for National Immunization Programs
Sponsored by Sanofi Pasteur
Saturday, March 3, 2018, 10:15 - 12:15hrs, Room Libertador A

    Juan Pablo Torres (Chile)

  • Lessons Learned from Recent Childhood Immunization Programs
    Marco Aurelio Safadi (Brazil)
  • Last Stage of Polio Eradication ‘End Game Strategy’, Changing Epidemiology and Increasing Role of Inactivated Polio Vaccines
    Emmanuel Vidor (France)
  • The Role of Vaccines, Immunization Schedules, and Coverage in Prevention of Pertussis in Children
    Ulrich Heininger (Switzerland)
  • Challenges of the New Vaccines Introduction into Public Health Programs: The Example of Dengue Vaccination

    Marco Aurelio Safadi (Brazil)

    Conclusions and Wrap-Up
    Juan Pablo Torres (Chile)
Pertussis; Protection Throughout Life
Sponsored by GSK
Saturday, March 3, 2018, 12:30 - 13:45hrs, Libertador C
    Welcome and Introduction

    Expert Panel Discussion:
  • Disease Burden of Pertussis and the Need for Life Course Prevention Strategies
  • Where Do We Stand Today with Pertussis Prevention? Achievements and Challenges
  • Maternal Immunization; a Strategy to Address the Burden in the Most Vulnerable Population

    Concluding Remarks and Q&A


    Carla Vizzotti (Argentina)

    Nicole Guiso (France)
    Marco Aurelio Safadi (Brazil)
    Eduardo Lopez (Argentina)

Strategic therapy for infections caused by resistant pseudomonas & ESBL producers: Options beyond  Carbapenems and Pipercillin/Tazobactam
Sponsored by MSD
Saturday, March 3, 2018, 17:00 - 18:00hrs, Libertador B

    Welcome and Introduction
    How Does the Surrounding Environment Affect My Choices?
    Clovis Arns da Cunha (Brazil)

  • Shifting the Paradigm in Timing and Treatment Options
    Fernando Ponce de Leon (Mexico)
  • Real-World Evidence and Clinical Data; Appropriate Antibiotic Therapy for Gram-Negative Infections
    in the ICU
    Jason Pogue (USA)

    Panel Discussion / Q&A
      Return to Top